Status:
COMPLETED
EffectS of CAnnabidiol in Patients: Evaluation
Lead Sponsor:
Nantes University Hospital
Conditions:
Substance-Related Disorders
Eligibility:
All Genders
18+ years
Brief Summary
Since its recent marketizing in France, the cannabidiol (CBD), a major component of cannabis, is used in many over-the-counter products in France. Some painful patients or patients suffering from addi...
Detailed Description
Physicians from algology and addictology departments will propose the study to all patients who meet the inclusion criteria during a medical consultation (in hospitalization or ambulatory care). If th...
Eligibility Criteria
Inclusion
- Minimum age of 18 years
- Patients for whom hospital specialists in algology or addictology have been requested (for hospitalized or ambulatory cares) during the inclusion period.
- Giving oral non opposition to participate.
Exclusion
- Adults under guardianship or curator
- Patients unable to respond to the research evaluation (cerebral function disorder, difficulty to understand, read or write French language).
Key Trial Info
Start Date :
May 6 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 26 2021
Estimated Enrollment :
746 Patients enrolled
Trial Details
Trial ID
NCT04405414
Start Date
May 6 2020
End Date
July 26 2021
Last Update
September 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nantes University Hospital
Nantes, Loire-Atlantique, France, 44093